PPT-Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI

The BRIGHT4 Trial Gregg W Stone MD On behalf of Yaling Han and the BRIGHT4 investigators Disclosure Statement of Financial Interest Dr Gregg W Stone Specific to this topic None. Nursing 201. Ms. Frasier. Summer 2014. Dimensional Analysis. Simple technique with a fancy name. Allows manipulation of units. Also referred as . factor label method . or the . unit factor method. Less errors. May 11, 2013. Objectives. Develop an approach for treating patients with iatrogenic coagulopathy. Understand recent changes in STEMI care. Review the ICH treatment protocol. Patient Care. Medical . Knowledge. (HIT). HEPARIN-INDUCED THROMBOCYTOPENIA. Unfractionated heparin (UFH) (beef > pork). Continuous iv infusion. Cardiopulmonary bypass. Low dose sq. Heparin flushes. Heparin-bonded catheters. Low molecular weight heparin. Central Iowa EMS Directors STEMI Task Force is striving to improve the patient outcomes of ST elevation myocardial infarctions. . . Current members. Central . Iowa EMS Directors . Association . Eva Kline-Rogers, MS,RN,NP. University of Michigan, Ann Arbor, MI. Friday, June 3, 3011. No Conflict of Interest to Disclose. Hospitalizations in the U.S. Due to Acute Coronary Syndromes (ACS). Acute Coronary Syndromes*. EDOSG National STEMI Initiatives In Partnership with the HSR-DCC Maame Yaa A. B. Yiadom, MD, MPH, MSCI 62 Emergency Departments 15% do not have formal STEMI screening 14% use “chest pain” as the Argatroban as an Alternative to Heparin for Vascular and Cardiovascular Surgery in Patients with a History of HIT By April Schmidt, RN, BSN Duke University Nurse Anesthesia Program My Background: BSN from East Carolina University in 1999 Content. Fibrinolytic agents. Clinical studies. Metalyse. ®. prescribing information. STEMI networks. Importance of time. Treatment strategies & guidelines. Registries. Take home points. Importance of time. Assist. Lect. Haider raheem. Digoxin. Digoxin is most useful for controlling ventricular response in persistent and permanent . atrial fibrillation . and . atrial flutter. . Digoxin also has a role in . Medication . Chart. Overview. This presentation will provide an overview of:. The layout of the WA Anticoagulation Medication Chart (WA AMC). The management of anticoagulants using the chart:. Low Molecular Weight Heparins (i.e. enoxaparin). , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. This s tandard applies to inpatients aged over 16 years treated with intravenous unfractionated h eparin. Do not use t his standard for the management of intravenous unfractionated heparin in s Presented by-. Dr. Varun Mittal, PG. Dept of Maxillofacial Surgery. SRM DENTAL COLLEGE, CHENNAI, INDIA. Which all patients?. Mostly cardiac or vascular disorders:. Atrial. fibrillation. Ischemic cardiac disease. STEMI reperfusion – an unmet need in many regions. Improving access to STEMI reperfusion. Definition and structure of a STEMI network. STEMI networks in practice. Table of contents. 2. Establish evidence-based, streamlined guidance on the purpose and practicality of establishing and running a STEMI network.